Alliance Pharma Regulatory News (APH)

7 May 2008 07:01

Alliance Pharma PLC07 May 2008 For immediate release 7 May 2008 RNS REACH ALLIANCE PHARMA PLC ("Alliance Pharma" or "the Company") Chief Executive appointed to ABPI Board Alliance Pharma plc (AIM: APH), the speciality pharmaceutical company, ispleased to announce that John Dawson, the Company's Chief Executive, has beenappointed to the Board of Management of the Association of the BritishPharmaceutical Industry (ABPI), the UK trade association representing companiesengaged in research, development, manufacturing and marketing of prescriptionmedicines. Mr Dawson was appointed to the ABPI Board in its recent elections and will servea one year term. John Dawson, Alliance Pharma's Chief Executive, said: "I am honoured to havebeen elected to the Board of Management of the ABPI and look forward to servingon it. I believe the ABPI performs an excellent role in promoting the interestsof all of the stakeholders in the UK's pharmaceutical industry and I lookforward to making a significant contribution to support its work, particularlyas important negotiations with Government are currently underway on the futurepricing systems for branded prescription medicines that are used by the NHS." For further information: Alliance Pharma plc + 44 (0) 1249 466966John Dawson, Chief ExecutiveRichard Wright, Finance Directorwww.alliancepharma.co.uk Buchanan Communications + 44 (0) 20 7466 5000Mark Court / Rebecca Skye Dietrich This information is provided by RNS The company news service from the London Stock Exchange